Chlamydia trachomatis is responsible for significant disease worldwide, including blinding trachoma (4), severe genitourinary pathology (13, 20) , and neonatal ophthalmitis and pneumonitis (2, 7) . Within this species of Chlamydia, 15 serovariants have been identified by the microimmunofluorescence test with polyvalent antisera (17) . Recently, this typing method has been improved by using major outer membrane protein (MOMP)-specific monoclonal antibodies (MAbs) (19) . The MOMP of C. trachomatis is antigenically complex and displays serovar, serogroup, and species specificities (1, 15) . MOMP gene (ompl) sequence comparisons among serovars has revealed four variable-sequence (VS) regions designated VS1, VS2, VS3, and VS4 (14) . MAbs that neutralize infectivity (8, 10, 22) bind serovar-specific epitopes that have been mapped to VS1 and VS2 (22) . Alternatively, serogroup-and species-specific determinants have been mapped to VS4 (1, 3, 16) . In addition to the importance of MOMP antigens for seroepidemiological evaluations and for the identification of serovariants that are responsible for infection, MOMP antigenic determinants may also be important for eliciting protective immunity (22) . Therefore, a molecular understanding of MOMP antigenic determinants is critical for the design of new sero-and molecular epidemiological assays as well as for rational vaccine development.
The entire ompl gene has been cloned and sequenced for serovars A (1); B, C, and L2 (14) ; and Li (11) . Recently, the ompl variant regions of serovars A to K and Li to L3 were sequenced by Yuan et al. (21) . On the basis of amino acid sequence comparisons for all four VS, the serovars can be separated into B complex, C complex, and G/F-related groups. Interestingly, prior classification of these serovars by polyvalent antisera or MAbs to MOMP-specific epitopes had grouped them similarly (17, 19) . This correlation most likely reflects the antigenic characteristics of the VS regions. The MAb typing method has resulted in the detection of three new chlamydial subtypes: D', I', and L2' (19 (Table 1) . Each sample was overlaid with 100 ,ul of mineral oil to prevent evaporation. The samples were placed in a programmable heat block (DNA thermal cycler; Perkin-Elmer-Cetus) for 35 cycles of heating to 94°C for 1 min, cooling to 37°C for 1 min, and heating to 72°C for 1 min. The presence and size of the amplified products were evaluated by agarose gel electrophoresis.
Two sets of oligonucleotide primer pairs were constructed to flank the 5' and 3' ends of the ompl sequence encompassing both VS1 and VS2 (VS1-VS2). The first set of primers was designed to amplify VS1-VS2 from serovars Ba, D, D', and L2' (B complex-related serovars). The second pair was designed to amplify VS1-VS2 from serovars I and I' (C complex-related serovars We utilized the PCR technique to obtain chlamydial DNA from unpurified elementary bodies and asymmetrically amplified this DNA to produce single-stranded DNA for direct sequencing of C. trachomatis ompi VS1, VS2, and VS4. C. trachomatis ompi VS1, VS2, and VS4 for serovars Ba, D, D', I, I', and L2' were amplified by using oligonucleotides constructed to the respective ompl regions ( Table 1) . The respective 5' primer was then used for the desired sequencing reaction. The nucleotide and inferred amino acid sequences of VS1, VS2, and VS4 for serovars D', I', and L2' are shown in Fig. 1 in comparison with their respective prototype sequences. Amino acid substitutions were detected in VS4 for serovar D'; in VS1, VS2, and VS4 for serovar I'; and in VS2 for L2'. We have confirmed the reliability of this approach by comparing the nucleotide sequences of serovars Ba, D, and I with previously published sequences (21) . This method is technically straightforward, rapid, and requires few organisms. These are distinct advantages over standard cloning and sequencing procedures.
The serovariants D', I', and L2' were identified by immunotyping techniques in which a two-step microimmunofluorescence test with MOMP-specific MAbs is used (19) . Recent epitope mapping studies by Baehr et al. (1) found that serovar-specific epitopes mapped to MOMP VS1 and VS2 for serovars A and L2, respectively. In addition, subspecies-, serogroup-, and species-specific epitopes were found to map to VS4. Stephens et al. (16) showed that the serovarspecific determinants of B, C, and L2 mapped to VS2 and that species-specific epitopes mapped to VS4. Although these MAbs used for typing (19) have not been mapped, the sequencing results for I' and L2' are probably consistent with the immunotyping and epitope mapping data for C complex-and B complex-related serovars, respectively. It has previously been proposed on the basis of presumed secondary structures that VS2 and VS4 are likely to contain serovar-specific antigens (14) . In addition, Yuan et al. (21) have sequenced A to K and Li to L3 and found considerable amino acid sequence heterogeneity in VS4 among serovars in the B complex-and C complex-related serogroups. These findings lend support to the proposition that VS4 may contain a serovariant-specific determinant or may modulate antibody binding to VS1 and VS2. However, it is also possible that sequence diversity in other regions of the MOMP may account for these findings and influence a nonlinear, conformational epitope. Additional epitope mapping studies are required to accurately define the complexity of antigenic determinants within VS4 for each C. trachomatis serovar and subtype.
On analysis of the nucleotide sequences for D' and L2', there are a few base pair substitutions in conserved regions of the MOMP gene (data not shown), which suggests that the emergence of these subtypes is not recent. Therefore, it is reasonable to assume that ompl accumulates point mutations that may be good markers of evolutionary and immuneselected changes within this gene. Genetic analysis of multiple samples for each serovar from different geographic regions of the world may allow for an understanding of the mechanisms of gene mutation and antigenic variation among C. trachomatis serovariants. The DNA extraction and sequencing method we describe will be useful for evaluating rapidly evolving base pair substitutions in ompi and allow for the identification of additional chlamydial subtypes. This technique provides a molecular signature of chlamydiae which should offer a more precise classification of C. trachomnatis than current immunotyping procedures. In addition, this method may be of particular value for evaluating the molecular epidemiology of chlamydiae in trachomaendemic areas. Usually, one or two serovars have been found to predominate in a certain geographic region. However, these serovars may represent only select types that can be recognized by current serological assays. The sequence determination of ompi variant regions of chlamydial isolates 
